ALKBH5 and acute myeloid leukemia: In tests in human AML cells, investigators observed highly potent and selective ALKBH5 inhibition; through inhibition of cell cycle progression, it suppresses tumor growth.[147] Two additional ALKBH5 inhibitors were discovered through a high‐throughput screening from a small molecule library by another group‐ Ena15 and Ena21.